Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Clinical Study Evaluating H1710 for Injection in Participants With Advanced Solid Tumors (NCT06992713) | Shenzhen Hepalink Pharmaceutical Group Co., Ltd. | 2025-06-18 |
Track Shenzhen Hepalink Pharmaceutical Group Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.